4Takano S, Tsuboil K, Tomonol Y, et al. Tissue factor,osteopontin, integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression[J]. Br J Cancer,2000,82(12):1967
5Weber G F, Ashkar S. Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers[J]. Brain Res Bull ,2000,53 (4) :421
6Bautista D S, Saad Z, Chambers A F, et al. Quantification of OPN in human plasma with an Elisa: basal levels in pre and postmenopausal woman[J]. Clin Biochem, 1996,29(3) :231
1Katagiri YU,Sleeman J,Fujii H,Herrlich P,Hotta H,Tanaka K,Chikuma S,Yagita H,Okumura K,Murakami M,Saiki I,Chambers AF,Uede T.CD44 variants but not CD44s cooperate with betal-containing integrins to permit cells to bind to osteopontin independently of argi
2Maeng HY,Choi DK,Takeuchi M,Yamamoto M,Tominaga M,Tsukamoto T,Tatematsu M,Ito T,Sakaki Y,Furihata C.Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N＇-nitro-N-nitrosogua
3Tuck AB,O'Malley FP,Singhal H,Tonkin KS,Harris JF,Bautista D,Chambers AF.Osteopontin and p53 expression are associated with tumor progression in a case of synchronous,bilateral,invasive mammary carcinomas.Arch Pathol Lab Med,1997,121:578～584.
4Furger KA,Allan AL,Wilson SM,Hota C,Vantyghem SA,Postenka CO,Al-Katib W,Chambers AF,Tuck AB.Beta (3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.Mol Cancer Res,2003,1:810～819.
5Singhal H,Bautista DS,Tonkin KS,O'Malley FP,Tuck AB,Chambers AF,Harris JF.Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.Clin Cancer Res,1997,3:605～611.
6Thalmann GN,Sikes RA,Devoll RE,Kiefer JA,Markwalder R,Klima I,Farach-Carson CM,Studer UE,Chung LW.Osteopontin:possible role in prostate cancer progression.Clin Cancer Res,1999,5:2271-2277.
8Sharp JA,Sung V,Slavin J,Thompson EW,Henderson MA.Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.Lab Invest,1999,79:869-877.
9Tuck AB.Chambers AF.The role of osteopontin in breast cancer:clinical and experimental studies.J Mammary Gland Biol Neoplasia,2001,6:419-429.
10Casson AG,Wilson SM,McCart JA,O'Malley FP,Ozcelik H,Tsao MS,Chambers AF.ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.Int J Cancer,1997,72:739-745.
2Semenza G L. Using two hands to flip the angiogenic switch[J]. Cancer Metastasis Rev, 2002, 19(1-2):59-65.
3Semenza G L. HIF-1, O2, and the 3PHDs: How animals signal hypoxia to the nueleus[J]. Cell, 2001,107 (1) 1-3.
4Van Lieshout T, Stanisz J, Espiritu V, et al. A hypoxic response induced in MatLyLu cells by cobalt chloride results in an enhanced angiogenic response by the chick chorioallantoic membrane[J]. Int J Oncol,2003,23(3) :745-750.
5Goldberg M A, Schneider T J. Similarities between the oxygensensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin[J]. J Biol Chem, 1994, 269(6) :4355-4359.
6Liu X, Kirschenbaum A, Yao S, et al. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclo-oxygenase-2 in metastatic human prostate cancer cell line [J]. Clin Exp Metastasis, 1999,17 (8) :687-694.
7Bunn H F, Poyton R O. Oxygen sensing and molecular adaptation to hypoxia[J]. Physiol Rev,1996,76(3):839-885.
8Lin C Z, McGough R, Aswad B, et al. Hypoxia induces HIF-1a and VEGF expression in chondrosarcoma cells and chondrocytes [J]. J Orthop Res,2004,22(6)1175-1181.
9McMahon G. VEGF receptor signaling in tumor angiogenesis[J]. Oncologist, 2000,5 ( Suppl1 ) : 3-10.
